生物启发的纳米酶作为尿路感染治疗的纳米诱
Yihong Zhang1, Wanling Liu1, Gen Wei1
1College of Engineering and Applied Sciences, Nanjing National Laboratory of Microstructures, Jiangsu Key Laboratory of Artificial Functional Materials, Nanjing University, Nanjing, Jiangsu 210023, China.
ACS nano
|March 14, 2024
概括
新的甲涂层菌纳米酶通过阻断细菌粘附和减少炎症来对抗尿路感染 (UTI). 这种双重作用的方法提供了一个有前途的策略来对抗FimH介导的感染.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 传染性疾病 传染性疾病
背景情况:
- 尿路感染 (UTI) 是一种常见的细菌感染,通常由FimH蛋白介导.
- 乌罗莫杜林的甘氨酸位点通过与FimH.相互作用来防止尿路感染.
- 目前针对尿路感染的抗粘合疗法没有针对活性氧物种和炎症.
研究的目的:
- 利用生物启发的纳米酶开发一种用于尿路感染的双作用治疗方法.
- 为了工程德克斯涂层 (DEC) 纳米颗粒作为纳米诱惑物对抗细菌粘附和炎症.
主要方法:
- 开发了超小的甲涂层 (DEC) 纳米颗粒.
- 对DEC与FimH的抗粘性质的评估.
- 在小鼠尿路感染模型中评估DEC的抗炎作用和疗效.
主要成果:
- 在DEC上的德克斯涂层有效地阻断了FimH粘附.
- DEC的菌成分显示出抗炎性质.
- DECs成功地治疗了小鼠的急性,重复性和导管相关的尿路感染,减少了细菌负载和组织损伤.
结论:
- 通过结合抗粘附和抗炎作用,DEC纳米颗粒提供了针对尿路感染的双重作用策略.
- 这种基于纳米酶的方法显示了治疗FimH诱导的尿路以外的感染的潜力.
相关概念视频
Urinary Tract Infection I: Introduction
1.3K
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
1.3K
Urinary Tract Infection II: Pathophysiology
1.5K
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
1.5K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
434
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
434
Urinary Tract Infection IV: Nursing Management
683
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
683
Microbial Biosensors
88
Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...
88
Microbiota of the Urogenital Tract
53
The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
53


